Mamegel, Magno .

HRN: 23-93-20  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/08/2024
10/14/2024
IVT
2.25g
Q24
CAP-HR
Waiting Final Action 

Indication:  EmpiricEmpirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: